Literature DB >> 3597779

Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

G M Hänsch, S Schönermark, D Roelcke.   

Abstract

The complement-mediated lysis is inefficient when complement and target cells are homologous with regard to the species. In erythrocytes from patients suffering from paroxysmal nocturnal hemoglobinuria (PNH), the species restriction is lost: PNH-erythrocytes (PNH-E) are susceptible to lysis by human complement. In human erythrocytes (huE) the species restriction is ascribed to an integral membrane protein, designated C8-binding protein (C8bp). In the present study, we tested membranes of PNH-E type III for the presence of C8bp. A protein with C8-binding capacity could not be detected. C8bp, which was isolated from the membrane of huE, inhibited the lysis of PNH-E by C5b-9 as well as the C9 polymerization. Thus, addition of C8bp restored the species restriction in PNH-E. In conclusion, we propose that lack of C8bp might represent the defect in PNH-E type III membranes, which is responsible for their enhanced lytic susceptibility towards lysis by the late complement components.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597779      PMCID: PMC442194          DOI: 10.1172/JCI113065

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Deviated lysis: lysis of unsensitized cells by complement. V. Generation of the activity of low pH or low ionic strength.

Authors:  U Rother; G Hänsch; E W Rauterberg; H Jungfer; K Rother
Journal:  Z Immunitatsforsch Immunobiol       Date:  1978-12

2.  Variations in the red cells in paroxysmal nocturnal haemoglobinuria.

Authors:  W F Rosse
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

3.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

4.  Binding of the eighth component of human complement to the soluble cytolytic complex is mediated by its beta subunit.

Authors:  J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

5.  Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; J P Leddy
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.

Authors:  K I Yamamoto; G Gewurz
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

8.  Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Authors:  C H Packman; S I Rosenfeld; D E Jenkins; P A Thiem; J P Leddy
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.

Authors:  G L Logue; W F Rosse; J P Adams
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.

Authors:  S I Rosenfeld; D E Jenkins; J P Leddy
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  20 in total

1.  Homologous species restriction of the complement-mediated killing of nucleated cells.

Authors:  H Yamamoto; P Blaas; A Nicholson-Weller; G M Hänsch
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

2.  Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.

Authors:  D M Lublin; E S Thompson; A M Green; C Levene; M J Telen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.

Authors:  C J Parker
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  C8 binding protein bears I antigenic determinants.

Authors:  P Blaas-Mautner; S Filsinger; B Berger; D Roelcke; G M Hänsch
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

Review 5.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

6.  The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.

Authors:  S Schönermark; S Filsinger; B Berger; G M Hänsch
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

7.  Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.

Authors:  H A Stafford; M L Tykocinski; D M Lublin; V M Holers; W F Rosse; J P Atkinson; M E Medof
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

8.  Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  M H Holguin; L R Fredrick; N J Bernshaw; L A Wilcox; C J Parker
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 9.  Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.

Authors:  E T Yeh; W F Rosse
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 10.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.